Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole and Prolactin in Schizophrenia Spectrum Disorders
NCT00468533Phase 4Unknown
- Sponsor
- Yu-Li Hospital
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in schizophrenia, schizoaffective disorder, schizophreniform disorder, sponsored by Yu-Li Hospital. Status: unknown.
02
Drugs
aripiprazole
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on NCT00468533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468533.